Miramar Capital, LLC Sarepta Therapeutics, Inc. Transaction History

Miramar Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 22, 2019	SELL	$72.81 - $156.91 $112,855 - $243,210	-1,550 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$112.21 - $151.95 $173,925 - $235,522	1,550 New	1,550 $229,000
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $458,681 - $652,224	-4,300 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $418,475 - $639,668	4,300 New	4,300 $572,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Miramar Capital, LLC with notifications on news.